Accord Healthcare Ltd: UK Public Sector Contracts Won & Awards

Large organisationCompanies House: Private Limited CompanyNorth HarrowNationwide (UK)Main market: Pharmaceutical products

Find a Tender organisation id4550

Procedures with an award830 award records · includes panel / call-off entries
i

How many tenders this supplier has won.

Tenders with at least one award to it. Award records are shown too, because one framework can carry many call-offs.

Public authorities3named on published awards
i

How many different public bodies have awarded to this supplier.

Buyers named on its awards, with duplicate names merged.

Last 12 months10awards · 3 in the prior 24 months · last 30 Mar 2026
i

Awards to this supplier in the last 12 months.

Award records dated in the last 12 months, against the two years before.

Contracts ending ≤18 months6end date published on 7 of 30 awards
i

Contracts that finish in the next 18 months.

Published contracts with an end date in that window. No end date, not counted.

A likely retender, not a certain one.

Delivery regions2most often Scotland
i

Where this supplier has delivered.

Delivery regions published on its awarded tenders. A tender with several regions counts in each.

Where the work was, not where the company is based.

Where they win
i

What kind of work is bought here.

Notices by procurement category (CPV). A notice with several categories counts in each.

30 lot-level observations (30 awarded lots, 100%, plus 0 envelope awards without lot links; pending awards included) · top CPV classes

3360 Pharmaceutical products30 observations · 100% · lots

Where they deliver
i

Where this supplier has delivered.

Delivery regions published on its awarded tenders. A tender with several regions counts in each.

Where the work was, not where the company is based.

ITL1 delivery regions on the notice · 8 of 8 awarded procedures publish one · a procedure with several regions counts in each

Scotland8 procedures · 100%
Nationwide (UK)1 procedures · 13%

Who they sell to
i

Which buyers publish the most notices here.

Buyers ranked by the number of notices, duplicate names merged.

Authorities named on this supplier’s published awards · ranked by distinct procedures · award records explode on framework and DPS panels

Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
i

What kinds of public bodies buy here.

Notices by the buyer’s type as published, otherwise by its name.

  • NHS & health100%(30 awards)
    30 of 30 awards are NHS & health (100%).

Share = of the 8 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.

Contracts ending
i

Contracts that finish in the next 18 months.

Published contracts with an end date in that window. No end date, not counted.

A likely retender, not a certain one.

Published end dates only · 7 of 30 awards carry one · not a retender forecast

ContractEndsPublished value
Cancer Medicines (Group 1)31 Jan 2027£1,925,364
Cancer Medicines (Group 2)31 Jan 2027£18,207,081
NP49425 Generic and Biosimilar Transition Medicines28 Feb 2027£64,103,740
Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines31 Jul 2027£3,594,493
Denosumab (Osteoporosis) and Ferric Carboxymaltose31 Jul 2027£2,254,091
Apremilast31 Oct 2027£663,520

Recent awards

Latest 30 of 30 award records naming this supplier

Award / procedureAuthorityAwardedAward value
NP49425 Generic and Biosimilar Transition MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Not publishedNot published
Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Not publishedNot published
Denosumab (Osteoporosis) and Ferric CarboxymaltoseThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Not publishedNot published
ApremilastThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Not publishedNot published
NintedanibThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Not publishedNot published
Cancer Medicines (Group 1)The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Not publishedNot published
Cancer Medicines (Group 2)The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Not publishedNot published
Lot 14 - Oxycodone Hydrochloride CapsulesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")Not publishedNot published
Lot 19 - Supply to NHSS Pharmaceuticals "Specials" ServiceThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")Not publishedNot published
Lot 4 - Oxycodone Hydrochloride Prolonged Release TabletsThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")Not publishedNot published
Data coverage & method
  • Source: Find a Tender OCDS award and contract releases. An award record is one award × this supplier; a procedure can carry many (panels, call-offs).
  • Market observations are awarded lots, or one envelope award when the notice publishes no lot links. Region = delivery ITL1 on the notice, not the supplier’s registered address.
  • Authority type: official OCDS UK contracting-authority type when the notice publishes one; otherwise a Tenderline name/id class; otherwise “not classified”. Purchasing hubs with no published type stay unclassified.
  • No award value is attributable to this supplier alone (values missing, multi-supplier, or framework / DPS ceilings).
  • Contract end dates: published on 7 of 30 awards; 6 end within 18 months.
  • Each figure’s own method and sample is behind its ; the long form is on Methodology.
  • Never shown: contact details, reliability or payment scores, affiliations, predicted wins.